Addressing mechanism bias in model-based impact forecasts of new tuberculosis vaccines
Abstract In tuberculosis (TB) vaccine development, multiple factors hinder the design and interpretation of the clinical trials used to estimate vaccine efficacy. The complex transmission chain of TB includes multiple routes to disease, making it hard to link the vaccine efficacy observed in a trial...
Main Authors: | M. Tovar, Y. Moreno, J. Sanz |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-09-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-023-40976-6 |
Similar Items
-
Model-based impact evaluation of new tuberculosis vaccines in aging populations under different modeling scenarios: the case of China
by: Mario Tovar, et al.
Published: (2024-02-01) -
Modeling the impact of COVID-19 on future tuberculosis burden
by: Mario Tovar, et al.
Published: (2022-06-01) -
On the impact of masking and blocking hypotheses for measuring the efficacy of new tuberculosis vaccines
by: Sergio Arregui, et al.
Published: (2016-02-01) -
Addressing misclassification bias in vaccine effectiveness studies with an application to Covid-19
by: Paolo Eusebi, et al.
Published: (2023-02-01) -
Addressing racial bias in wards
by: Tsai J, et al.
Published: (2018-09-01)